<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Aberrantly expressed GFRα-1/RET in patients with lacrimal adenoid cystic carcinoma is associated with high recurrence risk: a retrospective study of 51 LACC cases.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Aberrantly expressed GFRα-1/RET in patients with lacrimal adenoid cystic carcinoma is associated with high recurrence risk: a retrospective study of 51 LACC cases." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172c/7877180/ab01b366ae4e/cbm-18-199-g001.jpg"/> </div> <div class="text-side"> <h1>Aberrantly expressed GFRα-1/RET in patients with lacrimal adenoid cystic carcinoma is associated with high recurrence risk: a retrospective study of 51 LACC cases.</h1> <p>The representative photos of a patient and tissue section images of PNI with hematoxylin and eosin (H&amp;E) staining. (A) A 39-year-old female with ACC in the right lacrimal gland. (A1) The patient had ptotic eyelid, conjunctiva congestion with pain and limited eye motility in all directions of gaze. (A2) The overview of this patient on the 13rd day after surgery: eyelid edema, conjunctiva edema and congestion, eye motility dysfunction. (A3) The overview of this patient after 4 months from the operation: total ptosis with skin scar. (B1 and B2) LACC cells grow around the nerve; (B3 and B4) LACC cells grow closer to the nerve; (B5 and B6) LACC cells invade into the nerve. B1, B3, B5 (H&amp;E staining, 10 x); B2, B4, B6 (H&amp;E staining, 20 x ).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33628594/" target="_blank">33628594</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>